Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Classical Hodgkin's Lymphoma"'
Autor:
F. M. Abbasbeyli, P. A. Zeynalova, M. A. Vernyuk, A. A. Fedenko, T. Yu. Mushkarina, A. A. Melnikova, V. Yu. Kovalskaya, L. Yu. Grivtsova
Publikováno v:
Онкогематология, Vol 18, Iss 3, Pp 84-91 (2023)
Background. Classical Hodgkin’s lymphoma is a B-cell lymphoproliferative disease, the tumor substrate of which is Berezovsky–Reed–Sternberg cells, characterized by CD30, PAX-5, CD15 expression and the absence of CD3, CD45. In some cases, tumor
Externí odkaz:
https://doaj.org/article/89dc140af91445169227191cbb59466b
Autor:
Emilio Bellitti, Pierluigi Masciopinto, Pellegrino Musto, Elena Arcuti, Luca Mastracci, Giuseppina Opinto, Sabino Ciavarella, Attilio Guarini, Gerardo Cazzato, Giorgina Specchia, Eugenio Maiorano, Francesco Gaudio, Giuseppe Ingravallo
Publikováno v:
Current Oncology, Vol 29, Iss 9, Pp 6115-6124 (2022)
The metachronic onset of diffuse large B-cell lymphoma (DLBCL) after classic Hodgkin lymphoma (cHL) is a rare event affecting patients’ outcomes. However, although several studies have investigated the prognostic role of this event, little is known
Externí odkaz:
https://doaj.org/article/3b42cc6a7dcc492890bccd7c32cb54cd
Publikováno v:
Journal of International Clinical Dental Research Organization, Vol 14, Iss 1, Pp 74-78 (2022)
Hodgkin's lymphoma (HL) is a malignant disease of the lymphoid tissue originating from the germinal center and postgerminal center B-cells comprising 10% of all lymphomas and 0.6% among all cancers. Here, we report a case of a 22-year-old male with a
Externí odkaz:
https://doaj.org/article/46be0f48413e4e1591fef699d411dc14
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Classical Hodgkin’s lymphoma (CHL) accounts for 10% of all lymphomas. Nodular sclerosis and mixed cellularity accounts for nearly 80% of all CHL cases. The number of mast cells in CHL correlates with poor prognosis, is significantly higher in nodul
Externí odkaz:
https://doaj.org/article/1ca548c187294d159b90645483d4757a
Autor:
Elizabeth Katherine Anna Triumbari, Roberto Gatta, Elena Maiolo, Marco De Summa, Luca Boldrini, Marius E. Mayerhoefer, Stefan Hohaus, Lorenzo Nardo, David Morland, Salvatore Annunziata
Publikováno v:
Diagnostics, Vol 13, Iss 8, p 1391 (2023)
This study investigated the predictive role of baseline 18F-FDG PET/CT (bPET/CT) radiomics from two distinct target lesions in patients with classical Hodgkin’s lymphoma (cHL). cHL patients examined with bPET/CT and interim PET/CT between 2010 and
Externí odkaz:
https://doaj.org/article/924bdbd67db746ceb7a64d6c64aff114
Publikováno v:
中西医结合护理, Vol 7, Iss 1, Pp 89-92 (2021)
This paper reviewed the clinical data of 54 patients with relapsed or refractory classical Hodgkin's lymphoma treated with sintilimab, and summarized the key points of specialized nursing. In the treatment of refractory classical Hodgkin's lymphoma b
Externí odkaz:
https://doaj.org/article/3f24846b872246a6b19ae236938d2d62
Autor:
Gorana Gasljevic, Mateja Grat, Veronika Kloboves Prevodnik, Biljana Grcar Kuzmanov, Barbara Gazic, Luca Lovrecic, Helena Podgornik
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 120-129 (2020)
Chronic lymphocytic leukemia (CLL) typically pursues a prolonged course. Its transformation into a more aggressive lymphoma occurs in 2–8% of all patients. Most commonly, diffuse large B-cell lymphoma develops. Transformation into a classical Hodgk
Externí odkaz:
https://doaj.org/article/90a5271d420648feba6012b45ff6cd91
Autor:
YuanBo Xue, Xun Lai, RuiLei Li, ChunLei Ge, BaoZhen Zeng, Zhen Li, QiaoFen Fu, LiuFang Zhao, SuWei Dong, JinYan Yang, JiYin Guo, QingYin Meng, QingHua Tan, ZhenHui Li, HaiYan Ding, YanLei Zhang, ShaoHui Liu, Alex H. Chang, Hong Yao, RongCheng Luo
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundIn clinical applications of CAR T-cell therapy, life-threatening adverse events including cytokine release syndrome and neurotoxicity can lead to treatment failure. Outcomes of patients treated with anti-CD30 CAR T- cell have been disappoin
Externí odkaz:
https://doaj.org/article/10773d9ad59d4570bdf6971f6635786d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
I V Botezatu, T T Valiev, T E Dushenkina, K V Smirnova, R S Ravshanova, D M Maksimovich, A V Likhtenstein, V E Gurtsevich, A V Popa, N B Senyuta
Publikováno v:
Современная онкология, Vol 20, Iss 1, Pp 23-28 (2018)
Classical Hodgkin's lymphoma (cHL) is one of the many malignant tumors associated with the Epstein-Barr virus (EBV). It is shown that EBV-positive cases of cHL are distributed with different frequencies among all cases of the disease. The frequency o
Externí odkaz:
https://doaj.org/article/a40a19fc5879483a80f722e09ee097b0